These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15155991)

  • 1. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria.
    Emukah EC; Osuoha E; Miri ES; Onyenama J; Amazigo U; Obijuru C; Osuji N; Ekeanyanwu J; Amadiegwu S; Korve K; Richards FO
    Am J Trop Med Hyg; 2004 May; 70(5):556-61. PubMed ID: 15155991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.
    Oyibo WA; Fagenro-Beyioku AF
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):496-503. PubMed ID: 12693582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onchocerciasis in Imo state, Nigeria (2): the prevalence, intensity and distribution in the upper Imo river basin.
    Dozie I; Onwuliri C; Nwoke B
    Int J Environ Health Res; 2004 Oct; 14(5):359-69. PubMed ID: 15385215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced prevalence of onchocerciasis following mass treatment with ivermectin.
    Oyibo WA; Fagbenro-Beyioku AF
    East Afr Med J; 1997 May; 74(5):326-30. PubMed ID: 9337014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endemicity of onchocerciasis in some local government areas of Niger state.
    Idowu ET; Adewale B; Mafe MA; Appelt B; Bamgbose A
    Afr J Med Med Sci; 2004 Mar; 33(1):31-4. PubMed ID: 15490791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community response to repeated annual ivermectin treatment of onchocerciasis in Nigeria.
    Oyibo WA; Fagbenro-Beyioku AF
    Parasitol Res; 2002 Jul; 88(7):704-7. PubMed ID: 12107465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
    Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
    Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintaining compliance to ivermectin in communities in two West African countries.
    Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
    Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
    Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC
    East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of repeated community-based ivermectin treatment on the intensity of onchocerciasis in Nigeria.
    Oyibo WA; Fagbenro-Beyioku AF
    Rural Remote Health; 2003; 3(2):211. PubMed ID: 15877511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.
    Abanobi OC; Anosike JC
    Public Health; 2000 Sep; 114(5):402-6. PubMed ID: 11035465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
    Osue HO
    Ethiop J Health Sci; 2017 Mar; 27(2):129-138. PubMed ID: 28579708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
    Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
    Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of amenorrhoea after Mectizan treatment.
    Anosike JC; Abanobi OC
    Trop Geogr Med; 1995; 47(5):222-4. PubMed ID: 8553449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
    Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC
    Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.